(Jerusalem Post) Tzvi Joffre - Five patients recently discharged from Hadassah Medical Center were healthy and coronavirus-free after taking part in the first clinical trial of an innovative treatment. All five had been hospitalized in serious or critical condition. The drug Allocetra is based on research conducted by Prof. Dror Mevorach, director of the internal medicine and coronavirus departments at Hadassah. Mevorach explained, "Its activity is carried out by treating cells taken from a healthy donor and engineering them in the laboratory in a way that, when they are injected into the patient's body, will control the inflammation or storm of cytokines that is very harmful to patients."
2020-10-01 00:00:00Full ArticleBACK Visit the Daily Alert Archive